↑
OncoLens Raises Seed Funding To Streamline Cancer Treatment Planning
(Atlanta) OncoLens, a clinical decision software that focuses on oncology (cancer care), has closed a $1.35 million seed round led by BIP Capital and Atlanta Technology Angels (ATA). The platform...
Measurement and Collection of AONN+ Metrics Within an Automated Tumor Board Workflow
Background: The tumor board is the foundation of high-value multidisciplinary oncology care through coordinating teams of specialists. The nurse navigator is often a central hub of tumor boards, with...
Optimal Research and OncoLens Collaborate on Just-In-Time Clinical Trials for Cancer Patients
ROCKVILLE, Md. & TUCKER, Ga., Feb 19, 2018 (BUSINESS WIRE) -- Optimal Research, a patient identification and trial activation service provider, and OncoLens™, a software as a service (SaaS) tumor ...
